Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media

肺炎球菌从鼻咽生物膜携带转变为中耳炎

基本信息

项目摘要

DESCRIPTION (provided by applicant): Streptococcus pneumoniae (the pneumococcus) is an effective colonizer of the human nasopharynx (NP) that on occasion causes disease. However, due to widespread colonization, disease occurs often enough that S. pneumoniae is a leading cause of numerous infections including otitis media (OM) in children, with associated complications, such as hearing loss and impairment of language and cognitive development. Although pneumococcal pathogenesis has been studied for a long time, our understanding of the complex interactions between the human host and bacteria, especially as they relate to colonization and the transition to OM is incomplete. Epidemiologically, transition from colonization to OM is associated with concomitant virus infection or other assaults on the host defense system, but the specific mechanisms involved are not very clear. We recently made the novel observation that pneumococcal NP carriage in vivo is associated with biofilm formation and have shown that recapitulation of this phenotype in vitro requires aspects of the NP environment, including lower temperature, interaction with epithelial cells and limited nutrient availability. Moreover, we have discovered that perturbation of this environment specifically releases bacteria from the biofilm that readily disseminate to the middle ear (ME), causing more severe disease than either biofilm bacteria or bacteria grown in broth and have a unique gene expression profile, that has allowed us to identify several molecules required for bacterial release, dissemination, and induction of OM. The goals of these studies are to mechanistically explore the signals involved in pneumococcal release from NP biofilms (both pneumococcal biofilms and poly-microbial biofilms with common NP colonizing species), dissemination to, and survival in the ME using our novel epithelial cell-based biofilm models and animal models of colonization and infection, and we hypothesize that perturbing the NP environment with dispersants such as increased temperature (fever), nutrients and ATP (associated with cell damage) and virus infection (common disease trigger), that is highly associated with pneumococcal OM will induce release of biofilm bacteria with altered phenotypes associated with increased ability to cause infection of the ME. In the studies delineated herein, we will explore release of bacteria from biofilms in vitro and in vivo after exposure to physiological changes of the normal biofilm/NP environment (Aim 1) or to influenza A virus and respiratory syncytial virus infection (Aim 2). We will then study the ability of bacteria released in vitro or n vivo to induce OM. Finally, we will expand our transcriptome analyses of the bacterial populations using RNA-seq and identify and characterize molecules involved in bacterial biofilm release, dissemination to, and induction of OM (Aim 3). The studies will provide mechanistic information regarding the release of virulent bacteria from biofilms growing in vitro and in vivo and provide specific information of the environmental and bacterial factors responsible for virulence induction in vivo that can be used to inhibit the transition to otitis media.
描述(由申请人提供):肺炎链球菌(肺炎球菌)是人类鼻咽(NP)的有效定植菌,有时会引起疾病。然而,由于广泛定植,疾病频繁发生,肺炎链球菌成为儿童中耳炎 (OM) 等多种感染的主要原因,并伴有相关并发症,例如听力丧失、语言和认知发育障碍。尽管肺炎球菌发病机制已被研究了很长时间,但我们对人类宿主和细菌之间复杂相互作用的理解,特别是它们与定植和向 OM 的转变有关的理解还不完整。从流行病学角度来看,从定植到OM的转变与伴随的病毒感染或对宿主防御系统的其他攻击有关,但所涉及的具体机制尚不清楚。我们最近进行了新的观察,即体内肺炎球菌 NP 携带与生物膜形成相关,并表明在体外重现这种表型需要 NP 环境的各个方面,包括较低的温度、与上皮细胞的相互作用和有限的营养可用性。此外,我们发现,这种环境的扰动会特异性地从生物膜中释放细菌,这些细菌很容易传播到中耳 (ME),导致比生物膜细菌或肉汤中生长的细菌更严重的疾病,并且具有独特的基因表达谱,这使我们能够识别细菌释放、传播和诱导 OM 所需的几种分子。这些研究的目标是使用我们新型的基于上皮细胞的生物膜模型和定植和感染动物模型,从机制上探索肺炎球菌从 NP 生物膜(肺炎球菌生物膜和具有常见 NP 定植物种的多微生物生物膜)释放、传播到 ME 以及在 ME 中存活的信号,并且我们假设 与肺炎球菌 OM 高度相关的分散剂,如温度升高(发烧)、营养物质和 ATP(与细胞损伤相关)和病毒感染(常见疾病触发因素),将诱导生物膜细菌释放,其表型发生改变,与引起 ME 感染的能力增强相关。在本文所述的研究中,我们将探索暴露于正常生物膜/纳米粒子环境的生理变化(目标 1)或甲型流感病毒和呼吸道合胞病毒感染(目标 2)后,体外和体内细菌从生物膜中的释放。然后我们将研究体外或体内释放的细菌诱导 OM 的能力。最后,我们将使用 RNA-seq 扩展对细菌群体的转录组分析,并鉴定和表征参与细菌生物膜释放、传播和诱导 OM 的分子(目标 3)。这些研究将提供有关体外和体内生长的生物膜释放毒力细菌的机制信息,并提供负责体内毒力诱导的环境和细菌因素的具体信息,可用于抑制向中耳炎的转变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony A Campagnari其他文献

Anthony A Campagnari的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony A Campagnari', 18)}}的其他基金

Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
针对卡他莫拉菌预防和治疗中耳炎
  • 批准号:
    9265836
  • 财政年份:
    2016
  • 资助金额:
    $ 33.88万
  • 项目类别:
Targeting M. catarrhalis for Prevention and Treatment of Otitis Media
针对卡他莫拉菌预防和治疗中耳炎
  • 批准号:
    9915881
  • 财政年份:
    2016
  • 资助金额:
    $ 33.88万
  • 项目类别:
Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media
肺炎球菌从鼻咽生物膜携带转变为中耳炎
  • 批准号:
    8798654
  • 财政年份:
    2014
  • 资助金额:
    $ 33.88万
  • 项目类别:
Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media
肺炎球菌从鼻咽生物膜携带转变为中耳炎
  • 批准号:
    8719687
  • 财政年份:
    2014
  • 资助金额:
    $ 33.88万
  • 项目类别:
Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media
肺炎球菌从鼻咽生物膜携带转变为中耳炎
  • 批准号:
    9416819
  • 财政年份:
    2014
  • 资助金额:
    $ 33.88万
  • 项目类别:
Analysis of Novel Acinetobacter baumannii Adhesins
新型鲍曼不动杆菌粘附素的分析
  • 批准号:
    8355014
  • 财政年份:
    2012
  • 资助金额:
    $ 33.88万
  • 项目类别:
Analysis of Novel Acinetobacter baumannii Adhesins
新型鲍曼不动杆菌粘附素的分析
  • 批准号:
    8549948
  • 财政年份:
    2012
  • 资助金额:
    $ 33.88万
  • 项目类别:
Genetics & Biology of M. catarrhalis LOS in Otitis Media
遗传学
  • 批准号:
    7853873
  • 财政年份:
    2009
  • 资助金额:
    $ 33.88万
  • 项目类别:
M. catarrhalis pili:Role in Colonization and Infection
卡他菌毛:在定植和感染中的作用
  • 批准号:
    7201636
  • 财政年份:
    2006
  • 资助金额:
    $ 33.88万
  • 项目类别:
M. catarrhalis pili: Role in Colonization.
卡他菌菌毛:在定植中的作用。
  • 批准号:
    7383082
  • 财政年份:
    2006
  • 资助金额:
    $ 33.88万
  • 项目类别:

相似海外基金

Occurrence of antimicrobial resistance bacteria in wastewater of animal origin and its control by disinfection system combined with bacteriophage therapy
动物源性废水中耐药菌的产生及消毒系统联合噬菌体治疗的控制
  • 批准号:
    23K04097
  • 财政年份:
    2023
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fate of antimicrobial resistance genes in wastewater treatment processes focusing on their carrier bacteria and viruses.
废水处理过程中抗菌素耐药性基因的命运主要集中在其载体细菌和病毒上。
  • 批准号:
    23H01535
  • 财政年份:
    2023
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Monitoring of antimicrobial resistance in bacteria of veterinary importance
监测具有兽医重要性的细菌的抗菌药物耐药性
  • 批准号:
    10828042
  • 财政年份:
    2023
  • 资助金额:
    $ 33.88万
  • 项目类别:
(Meta)genomics of bacteria and antimicrobial resistance from different food production systems
不同食品生产系统的细菌(元)基因组学和抗菌素耐药性
  • 批准号:
    2751064
  • 财政年份:
    2022
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Studentship
Characterization of the antibacterial activity of some antimicrobial-derived metabolites and their involvement in the development of antimicrobial resistance in bacteria of animal origin
一些抗菌剂衍生代谢物的抗菌活性表征及其与动物源细菌抗菌素耐药性发展的关系
  • 批准号:
    RGPIN-2022-04264
  • 财政年份:
    2022
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Discovery Grants Program - Individual
Characterization of the antibacterial activity of some antimicrobial-derived metabolites and their involvement in the development of antimicrobial resistance in bacteria of animal origin
一些抗菌剂衍生代谢物的抗菌活性表征及其与动物源细菌抗菌素耐药性发展的关系
  • 批准号:
    DGECR-2022-00286
  • 财政年份:
    2022
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Discovery Launch Supplement
Prevalence of antimicrobial resistance genes among non-pathogenic bacteria population in the gut-microbiota
肠道微生物群中非致病菌群中抗菌素耐药性基因的流行率
  • 批准号:
    21K14994
  • 财政年份:
    2021
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Use of bacteriophage therapy to control antimicrobial resistance bacteria during wastewater treatment
使用噬菌体疗法控制废水处理过程中的抗菌药物耐药菌
  • 批准号:
    20K14864
  • 财政年份:
    2020
  • 资助金额:
    $ 33.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Detection and surveillance of antimicrobial resistance among enteric bacteria from raw retail meat and seafood in Iowa: A NARMS Retail Food Surveillance Project
爱荷华州生零售肉类和海鲜中肠道细菌抗菌药物耐药性的检测和监测:NARMS 零售食品监测项目
  • 批准号:
    10477244
  • 财政年份:
    2020
  • 资助金额:
    $ 33.88万
  • 项目类别:
Detection and surveillance of antimicrobial resistance among enteric bacteria from raw retail meat and seafood in Iowa: A NARMS Retail Food Surveillance Project
爱荷华州生零售肉类和海鲜中肠道细菌抗菌药物耐药性的检测和监测:NARMS 零售食品监测项目
  • 批准号:
    10247550
  • 财政年份:
    2020
  • 资助金额:
    $ 33.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了